Company profile
Tenvie Therapeutics
A commitment to transform the treatment of neurological and peripheral diseases
- Industry
- Biotechnology Research
- Employees
- 51
- Headquarters
- Brisbane, California
- LinkedIn followers
- 7,777
- Office locations
- 1
Tenvie Therapeutics company summary
Tenvie Therapeutics is a company in the Biotechnology Research industry, headquartered in Brisbane, California. On LinkedIn the company has around 51 employees and 7,777 followers. Warmrank detected 19 technologies across 13 categories on tenvie.com, including Amazon Web Services, Cloudflare, Cloudflare Bot Management.
What technology does Tenvie Therapeutics use?
Warmrank detected 19 technologies on tenvie.com, last checked July 2026. Click any tool to see other companies that use it.
Miscellaneous
HTTP/3
Open Graph
RSS
Webpack
GSAP
Redux
Amazon Web Services
WP Engine
Cloudflare Bot Management
Really Simple SSL & SecurityArtificial Intelligence
CDN
CloudflareCMS
WordPressDatabases
MySQLJavaScript libraries
LazySizesProgramming languages
PHPSSL/TLS certificate authorities
Webmail
Microsoft 365WordPress plugins
RankMath SEOAbout Tenvie Therapeutics
Tenvie Therapeutics is developing precision‑engineered small molecule therapies to address core drivers of neurological and peripheral diseases: neuroinflammation and cellular dysfunction. Leveraging its proprietary product engine, Tenvie has the unique ability to advance both fully CNS‑penetrant and peripherally restricted products across a broad portfolio. Tenvie’s most advanced programs, TNV262 and TNV108, are in Phase 1 clinical development. TNV262 is a fully CNS-penetrant NLRP3 inhibitor targeting cardiometabolic and neuroinflammatory indications, including obesity and cardiovascular disease, and multiple sclerosis. TNV108 is a peripherally restricted SARM1 allosteric inhibitor targeting peripheral neuropathies. Tenvie’s clinical pipeline is complemented by discovery-stage programs across a range of related indications.
Where is Tenvie Therapeutics located?
Tenvie Therapeutics lists 1 location.
Compare companies similar to Tenvie Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Tenvie Therapeutics tenvie.com | Biotechnology Research | 51 | - | Brisbane, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Tenvie Therapeutics
What does Tenvie Therapeutics do?
Tenvie Therapeutics is developing precision‑engineered small molecule therapies to address core drivers of neurological and peripheral diseases: neuroinflammation and cellular dysfunction. Leveraging its proprietary product engine, Tenvie has the unique ability to advance both fully CNS‑penetrant and peripherally restricted products across a broad portfolio. Tenvie’s most advanced programs, TNV262 and TNV108, are in Phase 1 clinical development. TNV262 is a fully CNS-penetrant NLRP3 inhibitor targeting cardiometabolic and neuroinflammatory indications, including obesity and cardiovascular disease, and multiple sclerosis. TNV108 is a peripherally restricted SARM1 allosteric inhibitor targeting peripheral neuropathies. Tenvie’s clinical pipeline is complemented by discovery-stage programs across a range of related indications.
What technology does Tenvie Therapeutics use?
Warmrank detected 19 technologies on tenvie.com, including Amazon Web Services, Cloudflare, Cloudflare Bot Management, GSAP, Google Trust Services, HTTP/3, LazySizes, Microsoft 365.
How many employees does Tenvie Therapeutics have?
Tenvie Therapeutics has around 51 employees on LinkedIn.
Where is Tenvie Therapeutics headquartered?
Tenvie Therapeutics is headquartered in Brisbane, California.
Build a lead list from companies like Tenvie Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.